BeiGene - Bathi operasional EBITDA BGNE
The flagship drug Brukinsa enables BeiGene, Ltd. (BGNE) to rapidly capture market share while strengthening the business's patent protection. Diversification through an extensive portfolio of immunological agents mitigates risks. This EBITDA chart captures the operating cash flow, where the metric stands at 1349.96. This biotech leader is outperforming industry behemoths by leveraging its proprietary testing platform to reduce costs and accelerate drug development timelines.
BeiGene (BGNE) - rincian metrik lan laporan keuangan
- kuotasi saiki lan rata-rata prakiraan nilai:
- rincian nilai pasar emiten:
- indikator nilai buku ekuitas:
- data tingkat utang lan likuiditas finansial:
- statistik bathi lan rasio pasar:
BGNE - Bathi resik perusahaan|Prakiraan bathi resik BeiGene, Ltd.|BGNE - Pangali P/E|Rasio prakiraan rega marang bathi beigene.com|BGNE - Pangali rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan BeiGene|BGNE - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan BeiGene|BGNE - Bathi resik saben saham sajrone 12 wulan pungkasan|Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan beigene.com|BGNE - Wutah bathi ing taun lumaku|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep BeiGene, Ltd.
Ringkesan analitik perusahaan:BGNE BeiGene Ltd
This indicator measures cash flow from operating activities before interest, taxes, depreciation, and amortization, allowing for an assessment of the actual efficiency of operational capital management. By analyzing the overall EBITDA of BeiGene, Ltd. (BGNE) through GURU.Markets tools, an investor can see the scaling dynamics of Brukinsa sales and the impact of the BeiGene, Ltd. (BGNE) innovative pipeline on the business's ability to generate cash during its global expansion phase.
Karo sapa BeiGene, Ltd. saingan
ONC - Bathi operasional sadurunge ngurangi amortisasi|HALO: Bathi operasional sadurunge ngurangi amortisasi|RVMD - Bathi operasional EBITDA|Ascentage Pharma (AAPG) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|CG Oncology Inc - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|URGN (UroGen) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Bicara Corp BCAX|Bathi operasional EBITDA PSNL|Bathi sadurunge mbayar bunga, pajak, lan amortisasi ERAS (erasca.com)|Bathi operasional EBITDA DCTH (Delcath Systems)|Y-mAbs Therapeutics Inc (YMAB) - Bathi sadurunge bunga, pajak, lan amortisasi|Aura Bio - Bathi operasional EBITDA|Pendapatan operasional sadurunge ngurangi amortisasi Candel Therapeutics CADL|ARAY: Bathi operasional EBITDA|Bathi operasional sadurunge potongan amortisasi SELLAS Life Sciences Group SLS|ACTU (Actuate Therapeutics) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Citius Oncology Inc. CTOR|Bathi sadurunge mbayar bunga, pajak, lan amortisasi TuHURA Biosciences, Inc. (HURA)|Protara Tx - Bathi operasional sadurunge amortisasi|Bathi operasional EBITDA FATE (Fate Therapeutics, Inc.)|Aadi Bioscience, Inc. (WHWK) - Bathi sadurunge bunga, pajak, lan amortisasi|TCRX: Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi CSBR (Champions Oncology)|xbiotech.com (XBIT) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|CVM (CEL-SCI) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi operasional sadurunge ngurangi amortisasi OSTX|RADX (radiopharmtheranostics.com) - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|Bathi operasional EBITDA ARTV|adlainortye.com - Bathi operasional sadurunge amortisasi|Veru Pharma - Bathi operasional sadurunge ngurangi amortisasi|Pendapatan operasional sadurunge ngurangi amortisasi Tempest Therapeutics Corp (TPST)|Xilio - Bathi operasional EBITDA|RENB: Bathi sadurunge mbayar bunga, pajak, lan amortisasi|MURA: Bathi operasional EBITDA|Bathi operasional sadurunge potongan amortisasi Kairos Pharma KAPA|Bathi sadurunge mbayar bunga, pajak, lan amortisasi OnKure Therapeutics, Inc.|Bathi operasional sadurunge amortisasi GDTC (CytoMed)|Bathi operasional EBITDA CRIS|APLM - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi operasional EBITDA THAR (Tharimmune)|ADVB - Bathi operasional sadurunge ngurangi amortisasi|Genprex, Inc - Bathi operasional EBITDA|CLDI - Bathi operasional EBITDA|Sunshine Biopharma, Inc. (SBFM) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi operasional sadurunge amortisasi XBIO|SLRX (Salarius Pharmaceuticals, Inc.) - Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi Purple Biotech Ltd (PPBT)|Bathi operasional EBITDA AONC|CKPT - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Elevation Oncology ELEV|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi ICAD|IKNA: Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi NTBL (Notable Labs Ltd)|VIRX: Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi MorphoSys Corporation|Bathi operasional sadurunge ngurangi amortisasi NAYA|Bathi operasional EBITDA ascentage.com
